Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M11,981Revenue (TTM) $M3,059Net Margin (%)24.7Altman Z-Score1.9
Enterprise Value $M14,788EPS (TTM) $2.6Operating Margin %44.8Piotroski F-Score5
P/E(ttm)16.5Beneish M-Score-1.9Pre-tax Margin (%)40.2Higher ROA y-yY
Price/Book4.410-y EBITDA Growth Rate %--Quick Ratio0.6Cash flow > EarningsN
Price/Sales4.15-y EBITDA Growth Rate %--Current Ratio0.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %77.3ROA % (ttm)9.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)29.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M276ROIC % (ttm)16.8Gross Margin Increase y-yN

Gurus Latest Trades with HOLX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

HOLX is held by these investors:

HOLX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2017-11-20Sell1,023$39.849.09view
ULLIAN ELAINEDirector 2017-11-13Sell9,282$40.57.31view
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2017-11-08Sell1,256$39.2910.61view
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2017-11-06Sell538$39.410.3view
Levy Lawrence MDirector 2017-10-10Sell9,596$36.8118.07view
Levy Lawrence MDirector 2017-10-09Sell7,138$37.3816.27view
Levy Lawrence MDirector 2017-09-07Sell7,139$39.0411.32view
ULLIAN ELAINEDirector 2017-08-03Sell6,902$40.128.33view
Oberton Karleen MarieCorp. VP & Chief Acctg Officer 2017-07-17Sell4,704$45.19-3.83view
ULLIAN ELAINEDirector 2017-07-03Sell8,849$45.28-4.02view

Quarterly/Annual Reports about HOLX:

News about HOLX:

Articles On GuruFocus.com
Hologic Announces Pricing of Offering of $1 Billion of Senior Notes Jan 16 2018 
Hologic Announces Offering of $1 Billion of Senior Notes Jan 16 2018 
Namal Nawana Elected to Hologic Board of Directors Jan 11 2018 
Hologic to Announce Financial Results for the First Quarter of Fiscal 2018 on Thursday, February 8, Jan 08 2018 
Hologic Preliminary Revenues Increase 8% to Approximately $791 Million in the First Quarter of Fisca Jan 08 2018 
Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligibl Jan 04 2018 
Hologic to Present at the 36th Annual J.P. Morgan Healthcare Conference Jan 02 2018 
Third Respiratory Assay Now FDA Cleared on Hologic's New Panther Fusion® System Dec 06 2017 
Report: Developing Opportunities within Hess, Hologic, UnitedHealth Group, NewJersey Resources, Masi Dec 04 2017 
Hologic Signs Development and Distribution Agreement with Clarius Mobile Health for Innovative Ultra Nov 26 2017 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat